Navigation Links
Hunter Shkolnik of Rheingold Valet Moves to Napoli Bern Ripka, LLP
Date:7/12/2011

NEW YORK, July 12, 2011 /PRNewswire/ -- After more than fifteen (15) years as a Senior Partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, Hunter Shkolnik has joined Napoli Bern Ripka, LLP ("Napoli Bern") as a Senior Partner of the firm, which will henceforth be known as Napoli Bern Ripka Shkolnik, LLP. Paul Napoli said: "Mr. Shkolnik led the complex and mass tort litigation team at Rheingold, Valet and he has long been active nationally as a leader in Pharmaceutical and Mass Tort litigations. We expect that he will continue to do so in the future".

Mr. Shkolnik has concentrated his areas of practice to the trial of significant personal injury cases primarily in the area of drug, medical device, automobile, heavy truck and aviation related product liability and medical malpractice actions. He serves as a chairman, leader or court appointed representative on Plaintiffs' Steering Committees in various consumer class actions and drug and medical device mass tort litigations including: In re: Toyota Sudden Acceleration Litigation 10:2151: Member, Liaison Counsel Committee For Personal Injury and Wrongful Death Claimants; In re: Oral Sodium Phosphate Solution- Based Products Liability Litigation 09:2066 Co-Lead Counsel; In re: Medtronic Sprint Fidelis Lead Litigation Member, Plaintiffs' Steering Committee; In re: Kaba Simplex Locks Marketing and Sales Practices Litigation; In re: POM Wonderful LLC Marketing and Sales Practices Litigation; In re: Medtronic Implantable Cardiac Defibrillators Litigation 05:1726 Member, Plaintiffs' Steering Committee; In re: Guidant Corp Implantable Defibrillators Products Liability Litigation 05:1708, Plaintiffs' Steering Committee; In re: Nuvaring Products Liability Litigation; New Jersey Levaquin Mass Tort Litigation-Discovery Co-Chair; New Jersey Nuvaring Litigation-Liaison Counsel; Co-Liaison Counsel New Jersey Metaclopromide Mass Tort Litigation. Hunter was a member of the
'/>"/>

SOURCE Napoli Bern Ripka Shkolnik, LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Gene Hunters Fine-Tune Marker for Common Obesity Gene
2. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
3. Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.
4. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
5. Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010
6. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
7. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
8. GeneGos ToxHunterâ„¢ Suite of Tools and Content for Systems Toxicology Research Is Now Available
9. Uroplasty to Present at Global Hunter Securities Inaugural Healthcare Conference
10. Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference
11. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") ... its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for ... Solta Medical, Inc. (NASDAQ: SLTM ) ("Solta") ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Mo., Oct. 26 Boehringer Ingelheim, a global pharmaceutical ... business Boehringer Ingelheim Vetmedica, Inc., announced today that it ... significant portion of the Fort Dodge Animal Health business. ... Australia, Canada and South Africa, as well as two ...
... (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th ... held October 28-29, 2009, at the Palace Hotel in San Francisco. ... Pacific Time. The conference will be webcast live with slides and ... at www.celltherapeutics.com . , , ...
Cached Medicine Technology:Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 2Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 3
(Date:7/9/2014)... sudden, acute episodes of low back pain are not ... pressure, wind direction and precipitation. Findings published in ... American College of Rheumatology (ACR), indicate that the risk ... speed or wind gusts, but was not clinically significant. ... nearly everyone experiences low back pain at some point ...
(Date:7/9/2014)... in almost all types of cancer sends the protein ... fuel a tumour,s uncontrolled growth, new research suggests. , ... a molecular trigger responsible for ratcheting up activity of ... makes the building blocks cancer cells need to keep ... called SREBP, controls the flow of messages to the ...
(Date:7/9/2014)... have found that fecal transplantation is effective and safe ... This is the result of a study led by ... Women,s Gastrointestinal Medicine at The Women,s Medicine Collaborative. The ... advance of print in the American Journal of ... C. diff , has increased to epidemic proportions over ...
(Date:7/9/2014)... has been a sharp increase in the number of ... the online, interactive service that allows patients to view ... schedule appointments, and renew prescriptions. , Over a six-year ... each year increased five-fold, while the number of ... to a study by Dr. David Gerber , ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... say, , MONDAY, July 13 (HealthDay News) -- It,s 6 a.m. ... does every morning, lets out a mix of low purr and ... me. , A new British study -- involving participants with names ... learn that this particular cry-purr combination is the most ...
... to Treat Diseases (HTDS.PK) www.htdsmedical.com - subsidiary, ... Co., Ltd for the Haemophilus influenza type b conjugate ... biggest manufacturer of Haemophilus influenza type b conjugate vaccine ... stage for Mellow Hope to be fully authorized to ...
... of cancer-prevention drug, , MONDAY, July 13 (HealthDay News) ... risk for highly aggressive prostate cancer, a new ... to determine the effect of alcohol consumption on prostate ... finasteride (Proscar, Propecia), a drug prescribed to prevent prostate ...
... Previous studies have found that postmenopausal women who ... therapy have increased their risk of developing progestin-accelerated breast ... curcumin, a popular Indian spice derived from the turmeric ... exposure to hormone replacement therapy. "Approximately 6 million ...
... , BALTIMORE,July 13 The National Federation of ... that have made outstanding contributions toward achieving the full integration of ... second annual Dr. Jacob Bolotin Awards honored eight innovators in the ... in Detroit on Wednesday, July 8. , , ...
... , Leading U.S. ... of competitors , , CINCINNATI, ... pharmacy, today announced that it will offer a 30-day supply of ... and prices below that of competitors, including Wal-Mart and Target, HealthWarehouse.com ...
Cached Medicine News:Health News:Cats Purrfect at Getting Needs Met, Study Shows 2Health News:Cats Purrfect at Getting Needs Met, Study Shows 3Health News:Hard To Treat Diseases (HTDS.PK) Agreement With 2nd Largest Vaccine Manufacturer in China Yunnan Walvax Biotech Co 2Health News:Heavy Drinking Linked to Aggressive Prostate Cancer 2Health News:Heavy Drinking Linked to Aggressive Prostate Cancer 3Health News:Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy 2Health News:National Federation of the Blind Awards $50,000 2Health News:HealthWarehouse.com Announces $3.50 Prescription Drug Program 2
... over 20 years of experience in ... the Life Sciences, the Freedom EVO ... possibilities for expansion according to future ... software, Freedom EVOware, each system is ...
... EVO Clinical is an open platform for clinical ... in deck sizes of 75, 100, 150 ... instrument for your laboratory space and throughput requirements. ... features to allow new applications and to evolve ...
... liquid handling system that ... of up to three ... the same worksurface. Offered ... solutions for targeted applications ...
... The AccelNet Laboratory Automation Network ... clinical chemistry systems, an automated sample ... manager to create a single, powerful ... ideal for laboratories that need a ...
Medicine Products: